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Microvascular surgery is becoming a prevalent surgical practice. Replantation, hand 
reconstruction, orthopedic, and free tissue transfer procedures all rely on microvascular 
surgery for the repair of venous and arterial defects at the millimeter and submillimeter 
levels. Often, a vascular graft is required for the procedure as a means to bridge the 
gap between native arteries. While autologous vessels are desired for their bioactivity 
and non-thrombogenicity, the tedious harvest process, lack of availability, and caliber 
or mechanical mismatch contribute to graft failure. Thus, there is a need for an off-
the-shelf artificial vascular graft that has low thrombogenic properties and mechanical 
properties matching those of submillimeter vessels. Poly(vinyl alcohol) hydrogel (PVA) 
has excellent prospects as a vascular graft due to its bioinertness, low thrombogenic-
ity, high water content, and tunable mechanical properties. Here, we fabricated PVA 
grafts with submillimeter diameter and mechanical properties that closely approximated 
those of the rabbit femoral artery. In vitro platelet adhesion and microparticle release 
assay verified the low thrombogenicity of PVA. A stringent proof-of-concept in vivo test 
was performed by implanting PVA grafts in rabbit femoral artery with multilevel arterial 
occlusion. Laser Doppler measurements indicated the improved perfusion of the distal 
limb after implantation with PVA grafts. Moreover, ultrasound Doppler and angiography 
verified that the submillimeter diameter PVA vascular grafts remained patent for 2 weeks 
without the aid of anticoagulant or antithrombotics. Endothelial cells were observed 
in the luminal surface of one patent PVA graft. The advantageous non-thrombogenic 
and tunable mechanical properties of PVA that are retained even in the submillimeter 
diameter dimensions support the application of this biomaterial for vascular replacement 
in microvascular surgery.
Keywords: small diameter vascular graft, in  vivo testing, compliance matching, off-the-shelf vascular graft, 
microvascular graft
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inTrODUcTiOn
Microvascular surgery contributes widely to various surgical pro-
cedures, such as replantation and free tissue transfer (Griffin and 
Thornton, 2005), free flap surgery (Shen et al., 1988), orthopedic 
surgeries (Doi et al., 1977; Judet et al., 1981), and digital recon-
struction (Lanzetta, 1995). During these procedures, vascular 
grafts are required to anastomose blood vessels together, repair 
vascular defects, and restore blood flow. The gold standard of 
using autologous venous and arterial grafts, which is valued for 
their biocompatibility and non-thrombogenicity, is not without 
fault. Autologous grafts require tedious and time-consuming 
harvesting processes and may be limited supply due to comor-
bidities that affect the vasculature. Moreover, venous autologous 
grafts lack mechanical integrity while autologous grafts have a 
propensity for aneurysm formation (So, 1998).
Synthetic small diameter vascular grafts (with diameter 
<6  mm) made of expanded polytetrafluoroethylene (ePTFE) 
are widely available today as alternatives to autologous vascular 
grafts. However, ePTFE grafts are plagued by rapid thrombosis 
and lack of long-term patency and efficacy caused by mechanical 
mismatch with the native artery (Uchida et al., 1989; Sarkar et al., 
2007). The problems of ePTFE grafts are further magnified in the 
submillimeter scale, where the low shear stress and flow, and high 
risk of blood stasis can lead to rapid graft thrombosis and failure 
(Barnes, 1980; Sarkar et al., 2006). ePTFE grafts with 1 mm diam-
eter have all failed after implantation in vivo, showing rapid and 
extensive thrombosis within a few days of implantation (Lidman 
et al., 1980; Ganske et al., 1982; Harris and Seikaly, 2002). Thus, 
the development of a new type of off-the-shelf synthetic vascular 
graft with submillimeter diameter for microvascular surgery is 
needed.
Poly(vinyl alcohol) hydrogel (PVA) is widely used for vari-
ous biomedical purposes, including the production of artificial 
meniscus (Kobayashi et  al., 2005), hemodialysis membrane 
(Barzin and Madaeni, 2007), heart valve (Wan et al., 2002), arti-
ficial vitreous fluid (Lamponi et al., 2012; Feng et al., 2013), and 
cardiac patch with drug delivery capability (Fathi et  al., 2013). 
PVA is an excellent candidate as a small diameter vascular graft 
due to its non-immunogenic, bio-inert, and mechanically tunable 
properties (Chaouat et al., 2008; Cutiongco et al., 2015a, 2016). 
Herewith, we sought to tune the mechanical properties of sub-
millimeter diameter PVA grafts. Characterization of mechanical 
and thrombogenic properties of the submillimeter PVA grafts 
will be performed. Demonstration of efficacy of PVA graft in 
stringent in vivo conditions submillimeter diameter will reiterate 
the potential of this material as a new vascular graft material for 
microvascular surgical applications.
MaTerials anD MeThODs
Fabricating PVa Vascular grafts
Fabrication of grafts made from PVA hydrogel (PVA graft) 
was performed according to previous studies (Cutiongco et al., 
2015b, 2016). Hypodermic needle [0.9  mm outer diameter 
(OD)] and carbon rod (1 mm OD) were used to fabricate PVA 
vascular grafts. Cylindrical molds were plasma cleaned (60 W, 
8  mL/min O2 gas) for 1  min to improve adherence of PVA. 
The mold was then immediately immersed in solution of PVA, 
crosslinker STMP, and NaOH, removed, and dried for 15 min 
at room temperature. An additional five layers of PVA were 
added and allowed to dry at 25°C for 3 days or 4°C for 3 days. 
Afterward, scaffolds were washed several times in phosphate-
buffered saline (PBS) and distilled deionized (DI) water before 
removal from the tubular mold. PVA tubes were gamma irradi-
ated (25  kGy) while immersed in water to obtain sterile PVA 
vascular grafts.
Mechanical Testing of submillimeter PVa 
grafts
Wall Thickness and Internal Diameter Measurement
Different sections of PVA vascular grafts (n = 5) hydrated in water 
were cut into ~1  mm cross-sections and imaged using optical 
microscope (Nikon Eclipse TS100). The images were used to 
measure wall thickness and ID using ImageJ (NIH).
Radial Compliance Test
At hydrostatic pressures of 80 and 120  mmHg, images of the 
distended PVA vascular grafts (n = 6) were taken using a ster-
eomicroscope (Nikon SMZ745T). Compliance was calculated as 
the percent change in PVA vascular graft diameter from 80 to 
120 mmHg (Chaouat et al., 2008).
Burst Pressure Test
Nitrogen gas was slowly released into closed-ended PVA vascu-
lar grafts (n = 3) until scaffold rupture. Pressure at failure was 
denoted as the burst pressure.
Suture Retention Test
A single throw of 6/0 Vicryl suture (Ethicon) was passed 
through one end of a PVA vascular graft at ~5 mm from the 
edge. The suture was attached to a receptacle, where water 
was added until rupture of the PVA graft. The weight of the 
receptacle and water was taken as suture retention strength 
(n = 4).
Uniaxial Test
PVA vascular grafts (1  cm length, n =  3) were tested using a 
uniaxial testing machine (INSTRON 3345) with a 10-N load cell, 
0.1-N preload, and crosshead speed of 10 mm/min. Measurements 
of various grafts were taken until break. Linear portions of the 
graphs were used to determine Young’s modulus.
scanning electron Microscopy of 
submillimeter PVa grafts
PVA vascular graft was air-dried overnight at ambient tempera-
ture, sputter coated with 10 nm platinum film (JEOL-JFC 1600 
coater), and visualized using scanning electron microscopy 
(SEM) (JEOL-JSM 6010LV).
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Blood compatibility of PVa
Incubation of PVA Tubes with Platelet Rich Plasma
In vitro blood compatibility assay was performed, as previously 
described (Cutiongco et al., 2015a). Blood samples were collected 
from healthy New Zealand White rabbits in polypropylene tubes 
primed with heparin (5  U/mL blood). Blood was centrifuged 
at 100 ×  g and 22°C for 12  min to collect platelet rich plasma 
(PRP). PVA vascular graft (1  mm ID, n =  3, internal surface 
area of 90 mm2), Silastic tubing (Dow Corning, n = 3, internal 
surface area of 60 mm2), and ePTFE tubing (Zeus, n = 3, internal 
surface area of 110  mm2) were weighed and washed in sterile 
0.9% NaCl solution (BBraun). Glass beads coated with bovine 
Collagen I (Invitrogen; 7.15  μg/mg sample) were placed in a 
polypropylene tube and included as a positive control. PRP was 
then added to the lumen of each tube or to the beads at 0.75 μL/
mg sample. Since the diameters of the tubes and beads used in 
this test were different, a constant mass of each sample was used. 
Tubes were sealed at both ends with sterile Luer lock combistop-
pers (BBraun). Subsequently, all samples were incubated for 1 h 
at 37°C with bidirectional X-axis rotation at 100  rpm. Resting 
samples of 100 μL PRP were also included. Tubular samples were 
kept for platelet morphology analysis using SEM (see Preparation 
of Samples for SEM Visualization), while PRP was then collected 
for subsequent flow cytometry analysis (see Flow Cytometric 
Analysis of Platelet Activation). Assay was done in triplicate for 
each sample.
Preparation of Samples for SEM Visualization
Tubular samples were washed in PBS and fixed using 2.5% glutar-
aldehyde at 4°C for 2 h. Thereafter, films were dehydrated using a 
series of increasing ethanol concentration. After complete drying, 
films were then coated and visualized under SEM, as described 
in Section “Scanning Electron Microscopy of Submillimeter PVA 
Grafts.”
Flow Cytometric Analysis of Platelet Activation
Aliquots of PRP (10 μL) were diluted with 200 μL of HEPES-
Tyrodes buffer (HTB; 137 mM sodium chloride, 2.7 mM potas-
sium chloride, 16 mM sodium bicarbonate, 5 mM magnesium 
chloride, 3.5 mM HEPES, 1% glucose, 2% bovine serum albumin, 
and pH 7.4) and incubated with antibodies against CD61/GPIIb/
IIIa (Abbiotec). Platelets were then washed with HTB and cen-
trifuged at 21,000  rpm and 4°C for 5  min. Platelets were then 
resuspended in 100 μL HTB and incubated with fluorescently 
conjugated secondary antibodies for 1 h. Samples were fixed with 
2% paraformaldehyde in HTB. Platelets were analyzed within 
24 h for scatter characteristics and expression of platelet markers 
using BD LSR Fortessa. Flow cytometry data were analyzed using 
FlowJo 4.0.
PVa Vascular graft implantation in rabbit 
Femoral artery with Multilevel arterial 
Occlusion
Animal study was done in accordance with approved guidelines of 
the Institutional Animal Care and Use Committee of the National 
University of Singapore. Male New Zealand White rabbits 
(3.5–4.0 kg, ~6 months old) were used in the study. Multilevel 
arterial occlusion in the left femoral artery was induced through 
embolization and ligation of the femoral artery before PVA graft 
anastomosis (Figure S1 in Supplementary Material).
After sedation and exposure of the left femoral artery, papa-
verine (1.43  mg/mL) was administered topically and intravas-
cularly to facilitate intra-arterial cannulation. Embolic particles 
(150–250 μm diameter, Boston Scientific) resuspended in equal 
volume of 0.9% sodium chloride and 4% gelofusine were injected 
into the left femoral artery. In a pilot study, the minimum dose 
of embolic particles needed to induce occlusion of the lower 
saphenous artery was determined by titration (data not shown). 
The embolic particles were flushed into the femoral artery with 
0.9% NaCl solution. The femoral artery was permanently ligated. 
A 4-mm length, encompassing the site of intra-arterial cannula-
tion and found between the ligatures, was resected to induce 
macro-vascular occlusion, thereby completing the induction of 
the multilevel arterial occlusion.
Immediately afterward, PVA vascular grafts with 4-mm 
length and 0.9- or 1-mm ID were implanted into the left femoral 
artery (PVA group). The size of graft implanted was chosen to 
match the caliber of the femoral artery. PVA vascular grafts 
were anastomosed using simple interrupted sutures (Ethilon, 
10-0) under operating stereomicroscope. During anastomosis, 
heparin (100  IU/kg) was administered intravenously. Ligation 
and reperfusion of left femoral artery did not exceed 3 h in all 
surgeries. Postanastomotic patency was confirmed by refill test 
and observation of pulsation in the postanastomotic vessel. All 
animals were treated with enrofloxacin (5 mg/kg) and buprenor-
phine (0.04 mg/kg) for 7 days postoperatively. The contralateral 
hindlimbs in each animal were included as an internal control 
(contralateral group, n = 7).
assessment of hindlimb Perfusion Using 
laser Doppler Flowmeter
The perfusion of the skin on the left dorsal foot was measured 
using laser Doppler flowmeter (Perimed PeriFlux System 5010 
with 1  mm diameter fiber-optic probe). Laser Doppler flow-
metry measurement of surface paw perfusion was performed 
immediately after surgery and at intervals afterward. Animals 
were sedated before measurement. To ensure consistency, laser 
Doppler probe was placed on the same location on the depilated 
dorsal foot, as marked by a small circular tattoo (AIMS animal 
tattoo). Measurements of surface perfusion were obtained from 
the stable readout of the laser Doppler flowmeter. All dorsal 
foot perfusion measurements were normalized to that of the 
contralateral group. For comparison, standard laser Doppler 
imaging (Perimed PeriFlux PIM 3) was performed and confirmed 
the validity of the readings obtained from the laser Doppler flow-
meter (Figure S2 in Supplementary Material).
Ultrasound Doppler
Examination of vascular graft patency during implantation was 
performed using ultrasound Doppler (GE Ultrasound Doppler 
Vivid S6, 8–13 MHz). Animals were lightly sedated and placed in 
prone position during the examination.
TaBle 1 | Mechanical properties of poly(vinyl alcohol) (PVa) grafts with submillimeter dimensions and reported values for rabbit femoral artery.
Tube internal 
diameter 
(μm, n = 5)
Wall thickness 
(μm, n = 5)
compliance 
(%, n = 6)
Burst pressure 
(mmhg, n = 3)
suture 
retention 
(g, n = 4)
Young 
modulus 
(kPa, n = 3)
elongation 
at break 
(%, n = 3)
Ultimate 
tensile strength 
(kPa, n = 3)
cross-linking at 25°c
1 mm  
diameter
1194 ± 29.62a 
(hydrated)
271.2 ± 70.47 4.00 ± 3.41 725 ± 137c 102 ± 16.9 553.1 ± 2.695b,c 436.0 ± 25.36c 84.4 ± 13.4b,c
0.9 mm 
diameter
1093 ± 63.61 
(hydrated)
287.6 ± 27.59 3.04 ± 2.56 868 ± 171c 76.6 ± 7.33a 388.7 ± 34.28b 465.8 ± 21.72c 53.7 ± 11.7b
cross-linking at 4°c
1 mm  
diameter
1185 ± 9.510a,b 
(hydrated)
273.8 ± 50.71 2.87 ± 0.14 269 ± 134c 90.3 ± 13.7 256.9 ± 61.34c 161.6 ± 41.22c 57.1 ± 9.90c
0.9 mm 
diameter
996.6 ± 29.85b 
(hydrated)
285.1 ± 47.74 3.29 ± 0.63 207 ± 104c 74.8 ± 5.90a 331.9 ± 90.54 130.7 ± 19.84c 44.0 ± 2.83
Rabbit femoral 
artery (Uchida 
et al., 1989)
938 ± 201 350–710 5.9 ± 0.5 2031–4225 200 ± 119 230 ND 998
aDenotes statistical significance between PVA graft and rabbit femoral artery.
bDenotes statistical significance between 1 mm internal diameter (ID) PVA graft and 0.9 mm ID PVA graft cross-linked at the same temperature.
cDenotes statistical significance of PVA graft with similar ID cross-linked at different temperatures.
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endpoint angiography
Digital subtraction angiography (GE Innova 2100) was performed 
at ~15  days postimplantation of the PVA grafts. Contralateral 
limbs were included as the internal control. Contrast agent 
(GE Omnipaque, 350 mg/mL) and 0.9% NaCl solution at a 1:1 
ratio were used for imaging. A midline incision was made on 
the sedated rabbit. The caudal abdominal aorta was cannulated 
near the iliac bifurcation for direct delivery of contrast agent 
through each iliac artery. Quantification of angiographic data was 
performed, as described previously (Silvestre et al., 2000; Iglarz 
et al., 2001).
histology
Heparin (100 IU/kg) was administered systemically before eutha-
nization with sodium pentobarbital (150  mg/kg). Muscle from 
both the implanted and contralateral limbs were harvested and 
fixed with 4% paraformaldehyde for 48 h. Tissues were embedded 
in Paraplast (Leica). Sections 15–20 μm thick were stained with 
standard hematoxylin and eosin (H&E) and Masson’s trichrome 
stain. Assessment of collateral formation and graft endothelializa-
tion was performed through detection of CD31 and α-SMA using 
Novolink kit (Leica).
statistical analysis
All data are presented as mean ±  SD. Statistical analysis was 
performed using one-way ANOVA with Tukey’s post  hoc test 
(GraphPad Prism v6.0). Differences were taken to be statistically 
significant at p < 0.05.
resUlTs
Tuning Mechanical Properties of 
submillimeter Diameter Vascular grafts
The lack of clinically available submillimeter diameter vascular 
grafts necessitates the creation of a new vascular graft. Thus, PVA 
submillimeter diameter vascular grafts were fabricated. Matching 
size and compliance of a synthetic vascular graft to the native 
recipient vessel is critical to maintain graft patency (Uchida et al., 
1989; Sarkar et  al., 2006). To better approximate mechanical 
properties of the rabbit femoral artery, PVA vascular grafts with 
uniform ID of 0.9 and 1  mm were fabricated at two different 
cross-linking temperatures of 25 and 4°C (Table 1).
The internal diameter (ID) and wall thickness between PVA 
grafts cross-linked at different temperatures but with similar ID 
showed minute differences. On the other hand, compliances of 
grafts cross-linked at 4°C were generally lower than those of tubes 
cross-linked at 25°C. Furthermore, burst pressure of grafts were 
significantly improved when grafts were cross-linked at 25°C 
compared to 4°C, showing at least a 2.7 times increase in mag-
nitude. Both Young’s modulus and ultimate tensile strength of 
1 mm ID PVA grafts were invariably improved when cross-linking 
temperature changed from 4 to 25°C. Similar to the observed 
improvement in burst pressure, the percent elongation at break 
was also drastically changed when cross-linking temperature was 
increased from 4 to 25°C.
Due to the compliance more closely approximating the rab-
bit femoral artery, together with better mechanical integrity as 
indicated by higher burst pressure and ultimate tensile strength, 
PVA grafts cross-linked at 25°C were chosen for implantation in 
the rabbit femoral artery. Under SEM, the PVA vascular grafts 
cross-linked at 25°C (afterward referred to simply as PVA graft) 
showed tubular structure with apparent even wall thickness 
(Figure  1A; Table  1) and random roughness along its luminal 
surface (Figure 1B).
Blood compatibility of submillimeter PVa 
Vascular grafts
In vitro blood compatibility assay was performed to determine 
platelet microparticle release and platelet morphology after 
contact with PVA grafts (Figure 2). Platelet microparticle release, 
as measured by the expression of the GPIIb/IIIa marker, is an 
important indicator of platelet activation (Gemmell et al., 1997). 
FigUre 1 | characterization of submillimeter diameter poly(vinyl alcohol) (PVa) vascular graft. (a) Photomicrograph of PVA vascular graft with 1 mm 
internal diameter. (B) Scanning electron microscopy (SEM) images show cross section and longitudinal section of 1 and 0.9 mm ID PVA vascular grafts cross-linked 
at 25°C. The longitudinal section shows surface roughness on lumen.
FigUre 2 | In vitro blood compatibility of PVa vascular grafts. (a) Percentage of microparticles expressing GPIIb/IIIa receptor released from total platelet 
count after contacting various surfaces (n = 3). *Denotes statistical significance with two-way ANOVA. (B) Morphology of platelets attached to various surfaces 
observed with SEM. Insets show higher magnification images of platelets.
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Platelets incubated in PVA grafts showed a statistically similar 
microparticle release profile with that of ePTFE, a material widely 
used for vascular grafts (Figure 2A). PVA also showed statistically 
similar platelet microparticle expression with Silastic, an inert 
material often used for blood-contacting tubing, and the resting 
control that did not contact any foreign material. Significantly, 
both PVA and ePTFE showed significantly lower microparticle 
release compared with the highly thrombogenic collagen-coated 
glass. PVA and ePTFE showed statistically similar microparticle 
release with the rest group, indicative of non-activated platelets 
(Yim et al., 2007). SEM further indicated the thrombogenic poten-
tial of collagen-coated glass through the fibrotic and clumped 
appearance of adhered platelets (Figure 2B). Meanwhile, plate-
lets were sparse on the PVA surface and less fibrous extensions 
(Figure 2B). Platelets that contacted ePTFE and silastic surfaces 
were rounder, indicative of the inactive platelet phenotype.
FigUre 3 | recovery of hindlimb surface perfusion after PVa graft 
implantation. Percent perfusion on PVA group given as the ratio of surface 
perfusion between dorsal foot of implanted limb and contralateral dorsal foot. 
Percent perfusion was obtained at different timepoints after PVA graft 
implantation (day 0).
TaBle 2 | summary of PVa graft implantation.
subject endpoint (days 
after surgery)
Diameter of PVa  
graft used (mm)
Patency at 
endpoint
PVA1 15 0.9 Patent
PVA2 17 1 Patent
PVA3 14 1 Occluded
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implantation of submillimeter PVa grafts 
in rabbit Femoral artery
PVA grafts were anastomosed to the left rabbit femoral 
artery with multilevel arterial occlusion (Figures S3–S5 in 
Supplementary Material). The multilevel occlusion of the 
femoral artery was induced to create a challenging environ-
ment to test the patency of submillimeter PVA grafts. After 
implantation of PVA grafts (Table  2), all PVA subjects had 
normal appearance and mobility 2  days postoperatively. All 
PVA subjects were alert and responsive with physiological 
posture and gait at the endpoint. Range of motion of all ankle 
joints and muscle tone were not affected. No signs of inflam-
mation or infection of the surgical area were seen, indicating 
the bioinertness of the PVA grafts.
The paw surface perfusion, which represents the overall flow 
contributed by both graft luminal patency and hindlimb collateral 
formation, was also measured (Figure 3). A notable minimum 
of percent perfusion was observed in PVA subjects immediately 
postoperative (day 0; PVA1 4.24% and PVA2 11.0%), indicative 
of the occlusion induced in the left femoral artery. More impor-
tantly, the percent perfusion on patent PVA grafts achieved or 
exceeded its preoperative level at endpoint (preoperative: PVA1 
69 and PVA2 80%; endpoint: PVA1 101.3 and PVA2 80.0%), 
indicating arterial recovery through graft patency and collateral 
network formation. In one instance, percent perfusion exceeded 
the level of the contralateral group.
Ultrasound Doppler was used as a means to estimate graft 
patency in situ (Figure 4). Ultrasound Doppler images showed 
continuous blood flow everywhere for PVA1 at both 4 and 
12  days postoperatively. Normal blood flow was observed 
throughout the femoral artery and the PVA graft. The PVA 
graft showed no leakage and no dilatation at both days of 
observation. Endpoint angiography confirmed the patency of 
two out of three PVA grafts, giving a primary patency rate of 
67% (Figure  5A). Significantly, all PVA limbs showed blood 
flow through the saphenous artery and metatarsal arteries 
using angiography. Analysis of angiograms showed that PVA 
limbs exhibited significantly higher pixel occupancy of blood 
vessels and more extensive collateral network as opposed to 
contralateral controls (Figure 5B).
Explanted PVA grafts showed that PVA1 showed some 
residual blood cells in the lumen (Figure  6A). In contrast, 
luminal tissue in PVA2 graft intensely stained with hematoxylin 
and its contour was similar to that of the graft wall, while the 
lumen of graft from PVA3 was completely filled with a thrombus 
(Figure 6A). While an unimplanted PVA graft did not show any 
positive signal, the entire luminal surface of the patent PVA2 graft 
indicated the presence of endothelial cells (Figure 6B). Masson’s 
trichrome staining also showed highly organized collagen fibers 
deposited in the area surrounding the PVA graft (Figure S6A in 
Supplementary Material).
Hindlimb muscles were also assessed for evidence of arte-
rial recovery. Muscle from PVA2 showed signs of recovery 
from ischemia, denoted by nuclei in the center of muscle fibers 
(Figure S6B in Supplementary Material). Hindlimb muscles 
in PVA limbs were bundled and rounded with uniform size 
(Figures  7A,B). Capillary density was significantly higher in 
PVA limbs compared to contralateral controls (Figure  7C). 
Additionally, mature collaterals surrounded by α-SMA-positive 
cells were increased in PVA, as opposed to the contralateral 
group (Figure 7D).
DiscUssiOn
Microvascular surgery is becoming more prevalent in the field yet 
alternatives to the use of autologous submillimeter grafts have not 
yet fully developed. There is a dearth of clinically efficacious arti-
ficial submillimeter diameter vascular grafts. The primary causes 
of failure of vascular grafts at this size scale are thrombogenicity 
and material mismatch (particularly, mismatch of diameter and 
compliance) with the native artery. PVA is commonly used for 
biomedical applications due to its bioinertness, its ability to 
imbibe water without compromising mechanical integrity and 
its tunable mechanical properties. To this end, PVA grafts with 
submillimeter diameter were mechanically tuned to create a new 
microvascular graft candidate.
At the microvascular size scale, surgery becomes increasingly 
difficult and increases risk of blood flow stasis, platelet activation 
and thrombosis (Sarkar et  al., 2006). Nonetheless, the charac-
teristics of PVA grafts were suitable to facilitate anastomosis at 
this dimension and maintain short-term patency. First, close 
approximation of the PVA graft mechanical properties, especially 
the diameter and the compliance, to the rabbit femoral artery 
likely aided maintenance of normal blood flow and propagation 
of pulsatile flow. In addition, PVA grafts were easily molded into 
submillimeter dimensions without loss of mechanical integrity; 
this contributed to the improved outcome of the anastomosis by 
FigUre 5 | Patency of femoral, saphenous, and metatarsal arteries, and PVa graft in PVa limbs. (a) Hindlimb perfusion was assessed by angiography. All 
PVA hindlimbs (n = 3) showed extensive collateral network proximally, while blood flow through the saphenous artery was maintained distally. Two out of three PVA 
grafts remained patent after implantation. A representative angiography from contralateral group (n = 5) demonstrated full patency of femoral artery and saphenous 
artery. Red arrow denotes PVA graft. Blue arrow denotes saphenous artery. Black arrow denotes metatarsal artery. Scale bar = 1 cm. (B) Digital examination of 
angiographs to measure total collateral vessel occupancy in PVA and contralateral group. Collateral vessel occupancy was measured from total pixel area of 
collaterals normalized to hindlimb area. *Denotes statistical difference using one-way ANOVA.
FigUre 4 | estimation of PVa graft patency using ultrasound Doppler. Representative ultrasound Doppler images were obtained from PVA1 limb. Ultrasound 
Doppler images were obtained from various areas of the femoral artery, including the graft, at both 4 and 12 days postsurgery. Color scale represents velocity 
direction, where red indicates blood flow from left to right of the artery.
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minimizing manipulation of the native vessel, which is fragile 
and susceptible to spasm and thrombosis during clamping 
(Fujimaki et al., 1977; Siemionow, 1987). Spontaneous luminal 
opening of PVA graft coupled with its elasticity, suture retention, 
and overall ease of handling likewise aided the anastomosis, 
which invariably contributed to graft patency (Siemionow, 1987; 
Chen et  al., 2001). In contrast, the use of the relatively stiff 
vascular graft made of ePTFE with 1 mm ID showed a dismal 
8% patency rate after 2 weeks in the rabbit femoral artery despite 
a good caliber match (Lidman et al., 1980). Ganske et al. (1982) 
reported even more drastic outcomes of thrombosis within 48 h 
postimplantation of ePTFE grafts implanted in the same location. 
The group further reported that the only patent ePTFE graft 
showed good tissue attachment but without any indication of 
endothelialization.
Second, improved resistance to thrombosis and patency can 
also be attributed to the low thrombogenic potential in vitro and 
endothelialization in  vivo of the submillimeter PVA vascular 
grafts. Flat PVA films were previously demonstrated by Ino et al. 
(2013) to induce similar platelet adherence and thrombin genera-
tion with the classic vascular graft material ePTFE. Recently, PVA 
graft thrombogenicity was tested using a baboon ex vivo assay, a 
more physiologically relevant system that mimics the hydrostat-
ics, hemodynamics and blood chemistry found in small diameter 
vascular grafts after implantation (Cutiongco et al., 2015a). The 
authors have reported that PVA grafts with diameter of ~3.75 mm 
have a lower platelet accumulation profile and total fibrin deposi-
tion compared with ePTFE. Thus, tuning the mechanical proper-
ties of submillimeter diameter PVA grafts did not deteriorate its 
low thrombogenic potential.
FigUre 6 | histological analysis of PVa vascular grafts. (a) Morphology 
of explanted PVA vascular grafts (n = 3). Hematoxylin and eosin (H&E) 
staining of sections of both patent (PVA1 and PVA2) and occluded PVA 
(PVA3) grafts (40×). (B) Endothelialization of patent PVA small diameter graft. 
Positive staining (brown) for CD31 was absent in unimplanted PVA and 
present in PVA vascular graft after 17 days postimplantation (40×). Insert 
shows higher magnification (100×).
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After 2 weeks of implantation, we observed the patency of 67% 
of PVA grafts. In at least one of the grafts, an endothelial layer 
was observed on the luminal surface. The observations are made 
more remarkable by the fact that the animal subjects did not 
receive any anticoagulant or antithrombotic regimen. Overall, 
the mechanical and surface properties of submillimeter diameter 
PVA graft are strongly advantageous for clinical application in 
microvascular surgery.
However, PVA vascular grafts are far from universal in its appli-
cation in microvascular surgery. Natural tapering compounded 
with variation in blood vessel caliber may cause mismatch at the 
distal anastomosis. The occlusion of PVA2 graft, which showed 
possible intimal hyperplastic tissue toward the distal end, sup-
ported this notion. It may be necessary to create PVA grafts 
with gradual tapering to accommodate natural changes in vessel 
diameter.
In addition to accommodating caliber, changes in compliance, 
tensile strength, and other mechanical properties should be 
accommodated. PVA can theoretically be adapted to accommo-
date multiple types of arteries from different anatomical location. 
Here, cross-linking degree of PVA was modified by manipulating 
the cross-linking temperature. PVA cross-linking is speculated 
to depend on the local concentration of alkaline, which is highly 
dependent on water evaporation rate. The myriad types of PVA 
available, with different acetylation degrees and molecular 
weight, present flexibility in the characteristics of the hydrogel 
obtained. For instance, this study and that of Ino et  al. (2013) 
cross-linked PVA with different acetylation degrees, resulting in 
PVA with different material properties. The crosslinker STMP 
and the alkaline content contributed by sodium hydroxide can 
also be easily modified to control the rate and extent of cross-
linking between the PVA chains and STMP. By increasing STMP 
and sodium hydroxide content, Chaouat et al. (2008) PVA graft 
(2 mm ID) matched mechanical properties of the rat abdominal 
aorta. The flexibility of the material and the cross-linking condi-
tions make PVA an outstanding material that can potentially 
be used as an off-the-shelf vascular graft for various vascular 
applications.
It should be noted that Chaouat et al. has previously shown 
patency of PVA grafts with millimeter dimensions in the rat 
abdominal aorta. While both rat abdominal aorta and rabbit 
femoral artery share similar diameters (Byrom et  al., 2010) 
different hemodynamics and hematology of the animal species 
may contribute to dissimilar graft performance. The high blood 
flow and shear stress in the aorta, combined with the decreased 
blood coagulation profile, possibly led to better patency in the rat 
model. In contrast, rabbits have coagulation profile more closely 
resembling those of humans (Byrom et al., 2010). Furthermore, 
the rabbit femoral artery has reduced blood flow from the mul-
tilevel arterial occlusion. It is known that increasing severity of 
distal arterial occlusion is correlated with lower graft patency 
and limb salvage in humans (O’Mara et al., 1981; Toursarkissian 
et al., 2002). Though the etiology is not well understood, the main 
suspect for graft failure in presence of poor blood outflow is the 
hemodynamic changes caused by distal vessel occlusion. The 
patency of the submillimeter PVA graft observed in this stringent 
rabbit model further exemplifies the usefulness of this graft for 
vascular applications.
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